Am J Transplant, Volume 17, Suppl 3 Archives - Page 38 of 181 - ATC Abstracts

2017 American Transplant Congress
Costimulatory Blockade in Delayed Graft Function.
J. Von Visger,¹ A. Diez,¹ U. Nori,¹ T. Pesavento,¹ R. Pelletier,² A. Rajab,² A. El Hinnawi,² H. Winters.³
¹Medicine, The Ohio State University, Columbus, OH; ²Surgery, The Ohio State University, Columbus, OH; ³Pharmacy, The Ohio State University, Columbus, OH
Background: Delayed graft function (DGF) contributes to higher risk of rejection, poorer graft survival, hospital length of stay (LOS), and other morbidities. Studies also suggest…
2017 American Transplant Congress
A Comparison of Medical Costs Among ABO-Compatible, -Incompatible, and -Minor Mismatched Living Kidney Transplantation: A Single-Center Study.
D. Fujimori, M. Okumi, K. Ungami, H. Ishida, K. Tanabe.
Urology, Tokyo Women's Medical University, Tokyo, Japan
[Background]ABO-incompatible living kidney transplantation (ABO-ILKT) is considered an effective alternative to deceased kidney transplantation. Although ABO-ILKT required extra strategies and suffered extra risks across ABO…
2017 American Transplant Congress
Outcomes Following Colectomy in Liver Transplant Recipients.
S. DiBrito, Y. Alimi, C. Haugen, I. Olorundare, D. Segev, J. Garonzik-Wang.
Surgery, JHU, Baltimore
Liver transplant recipients (LTR), like the general population, often require surgical procedures for non-transplant related issues. Given the need for immunosuppression and the physiologic impact…
2017 American Transplant Congress
Third Liver Transplantation, Outcomes, and the Impact of Previous Graft Survival.
M. Barry,¹ M. Gupta,² D. Goldberg,³ M. Levine,² D. Simpson,² K. Olthoff,² A. Shaked,² P. Abt.²
¹School of Medicine, University of Pennsylvania, Philadelphia, PA; ²Surgery, Division of Transplantation, University of Pennsylvania, Philadelphia, PA; ³Medicine, Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA
Introduction: Retransplantation with a third liver allograft is controversial with significant technical and medical challenges. National outcomes have not been described. We hypothesize that prior…
2017 American Transplant Congress
Surgical Outcomes of Pair-Watch Suturing Technique (PWST) for Duct-To-Duct Biliary Anastomosis in an Attempt to Reduce the Biliary Complications in Living Donor Liver Transplantation.
A. Tanemura, Y. Iizawa, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan
Objectives:Biliary stricture is one of the major complications after living donor liver transplantation (LDLT) with duct-to-duct biliary reconstruction. To prevent biliary stenosis, we have adopted…
2017 American Transplant Congress
Eliminating False Positive Virtual Crossmatch Results for Lung Transplant Candidates by Using Multiple Antibody Testing Platforms.
O. Timofeeva,¹ M. Kashem,² S. Geier,¹ D. Grogan,² S. Keshavamurthy,² J. Gomez-Abraham,² Y. Toyoda,² F. Cordova.²
¹Department of Pathology and Laboratory of Medicine, Temple University, Lewis Katz School of Medicine, Philadelphia, PA; ²Department of Cardiovascular Surgery, Temple University, Lewis Katz School of Medicine, Philadelphia, PA
Purpose: At present, immunologic risk for lung transplant patients is evaluated based on Virtual crossmatch (VXM) by comparing recipient's HLA antibodies detected by Single antigen…
2017 American Transplant Congress
Echinocandins in Lung Transplant Recipients (LTRs).
Y. AlJishi,¹ C. Rotstein,¹ D. Kumar,¹ A. Humar,¹ L. Singer,² S. Keshavjee,² S. Husain.¹
¹Transplant Infectious Diseases, University Health Network, Toronto, ON, Canada; ²Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada
Purpose: Echinocandins are a class of antifungal drugs that have activity against Aspergillus species. However, the use of echinocandins in LTRs is not well reported.…
2017 American Transplant Congress
Transcatheter Relief of Symptomatic Hepatic Venous Outflow Obstruction Following Pediatric Liver Transplantation.
B. Goldstein, G. Tiao, M. Alonso, N. Johnson, J. Heubi, K. Averin, J. Bucuvalas.
Cincinnati Children's Hospital, Cincinnati, OH
Background: Technical-variant allograft (TVA) pediatric liver transplantation (LT) is associated with vascular complications. Early recognition and treatment of hepatic venous outflow obstruction (HVOO) may be…
2017 American Transplant Congress
The Effect of Low-Dose IL-2 in Clinical Facial Transplantation: Molecular and Immunological Response.
N. Murakami,¹ T. Win,¹ T. Borges,¹ C. Lian,¹ G. Murphy,¹ E. Bueno,¹ R. Clark,¹ T. Strom,² B. Pomahac,¹ L. Riella.¹
¹Brigham and Women's Hospital, Boston; ²Beth Israel Deaconess Medical Center, Boston
BackgroundRegulatory T cells (Tregs) play a critical role in immune tolerance and low-dose recombinant IL-2 administration has been reported to expand Tregs in vivo. Although…
2017 American Transplant Congress
CD4⁺/CD8⁺ T Cell Ratio as a Predictive Marker for Early Graft Failure in Pig to Non-Human Primate Islet Xenotransplantation with Immunosuppression.
S. Choi,^1,3,4 H.-J. Kim,^1,2,3,4 I.-H. Yoon,^1,2 J.-S. Kim,^1,2,6 S.-J. Kang,^1,2,3,4 H.-Y. Nam,^1,2 B.-H. Min,¹ J.-S. Shin,^1,6 J.-M. Kim,^1,6 Y.-H. Kim,^1,5 W.-W. Lee,^1,2,3,4 C.-G. Park.^1,2,3,4,6
¹Xenotransplantation Research Center, Seoul National University College of Medicine, Seoul, Korea; ²Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; ³Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea; ⁴Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea; ⁵Department of Microbiology, Kyungpook National University School of Medicine, Daegu, Korea; ⁶Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul, Korea
Background: Outstanding results from nonhuman primate study put islet xenotransplantation with immunosuppression closer to the clinical application. To establish successful immune suppressive protocols, immune monitoring…